Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8857 - 8864 of 12007 results

Political and Economic Conditions Shaping America’s Energy Future
November 16, 2015| Blog| Viewpoint

U.S. Embassy in Tel Aviv Launches Online Videos about the Visa Process
November 16, 2015| Blog| Viewpoint

E-2 Visas May be Available to Israelis by end of 2015
November 16, 2015| Blog| Viewpoint

Three More FSMA Rules Finalized As the Year Comes to a Close
November 16, 2015| Blog| Viewpoint

Columbia Law Review Study of Fee Awards in Securities Class Actions Yields Surprising Results
November 16, 2015| Blog| Viewpoint

FDA Invites Genome Scientists to Come Play in the precision FDA “Sandbox”
November 13, 2015| Alert| Viewpoint

After Long Consideration, President Rejects Keystone Pipeline
November 13, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.
Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|

Health Law Diagnosed: PBM Update Spring 2025
June 10, 2025| Podcast|
